Peter A. Fasching
- Oncology top 0.1%
- Cancer Research top 0.05%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Co-authors
- Matthias W. BeckmannMichael UntchSibylle LoiblMichael P. LuxGϋnter von MinckwitzJens HuoberJens‐Uwe BlohmerChristian Jackisch
- Topics
- Breast Cancer Treatment Studies (197 papers)Advanced Breast Cancer Therapies (157 papers)HER2/EGFR in Cancer Research (123 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Peter A. Fasching
582 papers receiving 14.4k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Oncology 8.0k
- Cancer Research 6.7k
- Molecular Biology 3.1k
- Pulmonary and Respiratory Medicine 3.0k
- Pathology and Forensic Medicine 1.8k
Countries citing papers authored by Peter A. Fasching
This map shows the geographic impact of Peter A. Fasching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Fasching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Fasching more than expected).
Fields of papers citing papers by Peter A. Fasching
This network shows the impact of papers produced by Peter A. Fasching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Fasching. The network helps show where Peter A. Fasching may publish in the future.
Co-authorship network of co-authors of Peter A. Fasching
This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Fasching. A scholar is included among the top collaborators of Peter A. Fasching based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Fasching. Peter A. Fasching is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522breakdown → | 47 |
| 3 | 16 | |
| 4 | 1 | |
| 5 | 14 | |
| 6 | 13 | |
| 7 | 25 | |
| 8 | 2 | |
| 9 | 67 | |
| 10 | 7 | |
| 11 | 4 | |
| 12 | 3 | |
| 13 | 33 | |
| 14 | 89 | |
| 15 | 88 | |
| 16 | 27 | |
| 17 | 34 | |
| 18 | 265 | |
| 19 | 71 | |
| 20 | 66 |
About Peter A. Fasching
Peter A. Fasching is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 614 papers that have together received 14.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (197 papers), Advanced Breast Cancer Therapies (157 papers) and HER2/EGFR in Cancer Research (123 papers). The work is most often cited by research in Cancer Research (6.7k citations), Oncology (8.0k citations) and Pathology and Forensic Medicine (1.8k citations). Peter A. Fasching has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Matthias W. Beckmann, Michael Untch, Sibylle Loibl, Michael P. Lux, Gϋnter von Minckwitz, Jens Huober, Jens‐Uwe Blohmer, Christian Jackisch, J. Hilfrich and Carsten Denkert. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.